Share:
Peer-Reviewed Publication
Eur Heart J2025;46(29):2924-2927.August 1, 2025Journal Article

Coronary inflammation and cardiovascular risk in breast cancer after radiotherapy.

Christos P Kotanidis1,2, Thomas Halborg1, Pete Tomlins3, Kenneth Chan1, Sam Fry3, Gaëlle Jimenez4, Matthieu Lapeyre5, Nikant Sabharwal6, Keith M Channon1,6, Stefan Neubauer1,6, Sophie Jacob7, Charalambos Antoniades1,6
1Acute Multidisciplinary Imaging and Interventional Centre, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Level 6 West Wing, John Radcliffe Hospital, Headley Way, Headington, OX3 9DU Oxford, UK.
2Division of Cardiovascular Medicine, Heart and Vascular Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
3Caristo Diagnostics Ltd, Oxford, UK.
4Department of Radiation Oncology, Clinique Pasteur, Toulouse 31076, France.
5Department of Radiology, Clinique Pasteur, Toulouse 31076, France.
6Department of Cardiology, NIHR Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Headington, OX3 9DU Oxford, UK.
7Laboratory of Epidemiology, Institute for Radiation Protection and Nuclear Safety (IRSN), Fontenay-Aux-Roses 92260, France.

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.